TrialSignal transduction and targeted therapy2025

Transarterial chemoembolization plus atezolizumab and bevacizumab in patients with intermediate hepatocellular carcinoma: a single-arm, phase 2 trial.

Kang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.